Urgent and emergency care
Royal college to rewrite policy that said pharmacists should only treat new A&E patients when the case relates to medicine
While the Royal College of Emergency Medicine’s statement said pharmacists should only see emergency department patients for medicines-related matters, the Care Quality Commission says pharmacists can help give patients faster access to advice as part of a multidisciplinary emergency care team.
The Royal College of Emergency Medicine (RCEM) has said it will rewrite a position statment on the use of pharmacists in emergency departments which has been criticised as “disappointing” and “not patient-centred”.
The policy, issued in April 2019, said pharmacists should not see new emergency department patients unless the case specifically relates to medicines.
It also said that it does not support the use of pharmacists to treat emergency department patients “de novo” (from the beginning), except for issues directly pertaining to usage of medicines”.
But following criticism, the college has said it will redraw the policy statement and it is considering expanding its advanced clinical practitioners (ACP) scheme to include pharmacists later in 2019.
The RCEM says that it recommends the use of dedicated emergency department pharmacists to “work as part of a multidisciplinary team to help support the safe and efficient delivery of care to patients in the emergency department, as well as in clinical decision units and observation wards”.
Dan Greenwood, a graduate teaching assistant at the University of Manchester, who led a study that found that pharmacists were designated care providers for more than a third of patients in emergency departments, welcomed the RCEM’s emphasis on the pharmaceutical activities that pharmacists can contribute to emergency department patient care.
“However, given that there is a shortage of healthcare professionals to manage emergency department patients, and that pharmacists can — and do — manage certain emergency patients, [the] RCEM’s view that pharmacists should not manage patients de novo is not a patient-centred one,” he said.
“The RCEM position statement is a step in the right direction, but is certainly politically charged.”
Mark Borthwick, consultant pharmacist in critical care at Oxford University Hospitals Foundation Trust, said it was “fantastic” that the college was endorsing the role of pharmacists in the clinical area they work.
But he added: “It is disappointing that the statement doesn’t recognise the increasing role of prescribing among pharmacists, and actually actively discourages extended roles even though there are some pilot studies that find pharmacists can manage 8% of the emergency department workload as a prescriber, and up to 36% of the workload with a little extra training.”
Commenting on the position statement, Anne Joshua, head of pharmacy strategy at NHS England, cited a Care Quality Commission (CQC) report into urgent primary care services, published in June 2018, which said the use of pharmacists in delivering emergency care “can give patients faster access to advice from a [healthcare] professional in a variety of healthcare settings”.
“With additional training, pharmacists can provide urgent care under medical supervision as part of a multidisciplinary team,” the report adds.
Joshua added that the CQC report was a “real challenge to the [RCEM]”.
Chris Moulton, vice president of the RCEM, said the college valued pharmacists as “highly skilled healthcare professionals” who can fill a wide variety of roles in the emergency department.
He said the “most contentious” part of the college’s position statement was pharmacists’ role as primary practitioners in emergency care. He confirmed that the position statement would be rewritten.
“We think the right way for pharmacists to be primary practitioners is to go down the ACP credentialling route,” he said.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206680
Recommended from Pharmaceutical Press
This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.£57.00Buy now
Pharmacy Registration Assessment Questions 2 features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own. All questions are in line with current GPhC guidance, enabling you to prepare for the pharmaceutical pre-registration exam with confidence.£35.00Buy now
Pharmacy Registration Assessment Questions 3 is the third volume in a series that follows on from the previous, highly popular Pharmacy Registration Assessment Questions 2. It features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own.£35.00Buy now
Pharmacy Registration Assessment Questions features over 400 closed book and calculation questions. With the registration exam having gone through a complete transformation in 2016, this volume has been developed around the new General Pharmaceutical Council (GPhC) guidelines.£33.00Buy now